5
Views
2
CrossRef citations to date
0
Altmetric
Original Article

A Prospective Study of Opioid Rotation in Pain Due to Advanced Cancer

, , , , , & show all
Pages 39-46 | Published online: 04 Dec 2011

REFERENCES

  • Gutgsell T, Walsh D, Zhukovsky D, Gonzales F, Lagman R: A Prospective study of the pathophsiology and clinical characteristics of pain in a palliative medicine population. American Journal of Hospice and Palliative Care. 2003; 20(2): 140–148.
  • Portenoy RK: Cancer pain. Epidemiology and syndromes. Cancer. 1989; 63: 2298–2307.
  • Portenoy RK: Management of cancer pain. The Lancet.1999; 353: 1695–1700.
  • Hanks GW, Forbes K: Opioid responsiveness. Acta Anaesthesiol Scand. 1997; 41:134–138.
  • Mercadante S, Portenoy RK: Opioid poorly responsive cancer pain. Part1. Clinical consideration. Journal of Pain and Symptom Management. 2001; 21(2): 144–150.
  • Ballantyne JC, Mao J: Medical progress: Opioid therapy for chronic pain. 2003; 349(20): 1943–1953.
  • Portenoy RK: Tolerance to opioid analgesic: Clinical aspects. In: Hanks GW, editor. Palliative medicine: problem areas in pain and symptom management. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1994: 49–66.
  • Passik SD, Tolbert VE, Bruera E et al.: Central nervous system and Psychological complications of opioid therapy. Psychological Complications. 2003; 592–598.
  • deStoutz ND, Bruera E, Suarez-Almazor: Opioid rotation for toxicity reduction in terminal cancer patients. Journal of Pain and Symptom Management. 1995; 10(5): 378–384.
  • Mercadante S, Portenoy RK: Opioid poorly responsive cancer pain: Part 3. Clinical strategies to improve opioid responsiveness. J Pain Symptom Manage. 2001; 21: 338–354.
  • Bruera E, Pereira J, Watanabe S et al.: Opioid rotation in patients with cancer pain. Cancer. 1996; 78(4): 852–857.
  • Estfan B, LeGrand S, Walsh D, Lagman R, Davis M: Opioid rotation in cancer patients: Pros and cons. Oncology. 2005; 19(4): 511–516.
  • Ashby MA, Martin P, Jackson KA. Opioid substitution to reduce adverse effects in cancer pain management. Med. J Aust. 1999; 170(2): 68–71.
  • Enting RH, Oldenmenger WH, Rijt CC, Wilms EB, Elfrink EJ, Elswijk I, Sillevis Smitt PA. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Cancer. 2002; 94 (11): 3049–3056.
  • Muller-Busch HC, Lindena G, Tietze K, Woskanjan S: Opioid switch in palliative care, opioid choice by clinical need and availability. Europ J Pain 2005; 9: 571–579.
  • Mercadante S, Portenoy RK: Opioid poorly-responsive cancer pain. Part 2. Basic mechanisms that could shift dose response for analgesia. Journal of Pain and Symptom Management. 2001; 21(3): 255–264.
  • Davis MP: Opioid resistant pain in opioids in Cancer Pain eds. Davis M, Glare P, Hardy J, Oxford University Press, Oxford, UK, pp. 307–330.
  • Mercadante S: Opioid rotation for cancer pain; Rationale and clinical aspects. Cancer. 1999; 86(9): 1856–1866.
  • Davis MP, Varga J, Dickerson D, Walsh D, LeGrand SB, Lagman R: Normal-release and controlledrelease oxycodone: pharmacokinetics, pharmacodynamics and controversy. Supportive Care Cancer. 2003; 11: 84–92.
  • Strasser F: Promoting science in a pragmatic world: not (yet) time for partial opioid rotation. Supportive Care Cancer. 2005; 13:765–768.
  • Davis MP, LeGrand S, Lagman R: Look before leaping: Combined opiods may not be the rave. Supportive Care Cancer. 2005; 13:769–774.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.